[go: up one dir, main page]

MX2017009713A - Sal de tosilato de n-[3-[(4ar,7as)-2-amino-6-(5-fluoropirimidin-2- il)-4,4a,5,7-tetrahidropirrolo[3,4-d] [1,3]tiazin-7a-il]-4-fluoro- fenil]-5-metoxi-pirazin-2-carboxamida. - Google Patents

Sal de tosilato de n-[3-[(4ar,7as)-2-amino-6-(5-fluoropirimidin-2- il)-4,4a,5,7-tetrahidropirrolo[3,4-d] [1,3]tiazin-7a-il]-4-fluoro- fenil]-5-metoxi-pirazin-2-carboxamida.

Info

Publication number
MX2017009713A
MX2017009713A MX2017009713A MX2017009713A MX2017009713A MX 2017009713 A MX2017009713 A MX 2017009713A MX 2017009713 A MX2017009713 A MX 2017009713A MX 2017009713 A MX2017009713 A MX 2017009713A MX 2017009713 A MX2017009713 A MX 2017009713A
Authority
MX
Mexico
Prior art keywords
tetrahydropyrrolo
fluoropyrimidin
pyrazine
carboxamide
fluoro
Prior art date
Application number
MX2017009713A
Other languages
English (en)
Inventor
Andrew Coates David
Daniel Wolfangel Craig
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX2017009713A publication Critical patent/MX2017009713A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere a una sal de tosilato de N-[3-[(4aR,7aS)-2-amino-6-(5-fluoropirimidin-2-il)-4,4a,5,7-tetra hidropirrolo[3,4-d][1,3]tiazin-7a-il]-4-fluoro-fenil]-5-metoxi-pi razina-2-carboxamida.
MX2017009713A 2015-01-30 2016-01-22 Sal de tosilato de n-[3-[(4ar,7as)-2-amino-6-(5-fluoropirimidin-2- il)-4,4a,5,7-tetrahidropirrolo[3,4-d] [1,3]tiazin-7a-il]-4-fluoro- fenil]-5-metoxi-pirazin-2-carboxamida. MX2017009713A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562109733P 2015-01-30 2015-01-30
PCT/US2016/014423 WO2016122968A1 (en) 2015-01-30 2016-01-22 Tosylate salt of n-[3-[(4ar,7as)-2-amino-6-(5-fluoropyrimidin-2-yl)-4,4a,5,7-tetrahydropyrrolo[3,4-d][1,3]thiazin-7a-yl]-4-fluoro-phenyl]-5-methoxy-pyrazine-2-carboxamide

Publications (1)

Publication Number Publication Date
MX2017009713A true MX2017009713A (es) 2017-11-17

Family

ID=55275232

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017009713A MX2017009713A (es) 2015-01-30 2016-01-22 Sal de tosilato de n-[3-[(4ar,7as)-2-amino-6-(5-fluoropirimidin-2- il)-4,4a,5,7-tetrahidropirrolo[3,4-d] [1,3]tiazin-7a-il]-4-fluoro- fenil]-5-metoxi-pirazin-2-carboxamida.

Country Status (41)

Country Link
US (1) US10080758B2 (es)
EP (1) EP3250575B1 (es)
JP (2) JP6723250B2 (es)
KR (1) KR101950129B1 (es)
CN (1) CN107108657B (es)
AR (1) AR103406A1 (es)
AU (1) AU2016211827B2 (es)
BR (1) BR112017012149A2 (es)
CA (1) CA2969475C (es)
CL (1) CL2017001899A1 (es)
CO (1) CO2017007810A2 (es)
CR (1) CR20170287A (es)
CY (1) CY1122548T1 (es)
DK (1) DK3250575T3 (es)
DO (1) DOP2017000159A (es)
EA (1) EA031330B1 (es)
EC (1) ECSP17048768A (es)
ES (1) ES2768782T3 (es)
GT (1) GT201700166A (es)
HR (1) HRP20192240T1 (es)
HU (1) HUE048029T2 (es)
IL (1) IL252754A0 (es)
LT (1) LT3250575T (es)
MA (1) MA41420B1 (es)
MD (1) MD3250575T2 (es)
ME (1) ME03581B (es)
MX (1) MX2017009713A (es)
NZ (1) NZ732381A (es)
PE (1) PE20171333A1 (es)
PH (1) PH12017501356A1 (es)
PL (1) PL3250575T3 (es)
PT (1) PT3250575T (es)
RS (1) RS59730B1 (es)
SG (1) SG11201706038PA (es)
SI (1) SI3250575T1 (es)
SV (1) SV2017005478A (es)
TN (1) TN2017000332A1 (es)
TW (1) TWI574969B (es)
UA (1) UA119581C2 (es)
WO (1) WO2016122968A1 (es)
ZA (1) ZA201703937B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI574969B (zh) * 2015-01-30 2017-03-21 美國禮來大藥廠 甲苯磺酸鹽
WO2019094608A1 (en) 2017-11-08 2019-05-16 Denali Therapeutics Inc. Anti-bace1 antibodies and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT401651B (de) * 1994-06-14 1996-11-25 Biochemie Gmbh 7-(2-(2-aminothiazol-4-yl)-2-(z)- hydroximinoacetamido)-3-n,n- dimethylcarbamoyloxymethyl-3-cephem-4-
KR20100075679A (ko) * 2007-12-07 2010-07-02 화이자 인코포레이티드 트랜스-n-이소부틸-3-플루오로-3-[3-플루오로-4-(피롤리딘-1-일메틸)-페닐]-사이클로부탄카복스아미드의 토실레이트 염
RS54311B1 (en) * 2008-01-18 2016-02-29 Eisai R&D Management Co. Ltd. KONDEZOVANI AMINODIHYDROTIAZINE DERIVATIVE
TWI593692B (zh) * 2013-03-12 2017-08-01 美國禮來大藥廠 四氫吡咯并噻嗪化合物
TWI570127B (zh) * 2014-09-15 2017-02-11 美國禮來大藥廠 結晶型N-[3-[(4aR,7aS)-2-胺基-6-(5-氟嘧啶-2-基)-4,4a,5,7-四氫吡咯并[3,4-d][1,3]噻嗪-7a-基]-4-氟-苯基]-5-甲氧基-吡嗪-2-甲醯胺、其用途及醫藥組合物
TWI574969B (zh) * 2015-01-30 2017-03-21 美國禮來大藥廠 甲苯磺酸鹽

Also Published As

Publication number Publication date
MD3250575T2 (ro) 2020-03-31
SV2017005478A (es) 2018-02-09
PE20171333A1 (es) 2017-09-13
CY1122548T1 (el) 2021-01-27
KR101950129B1 (ko) 2019-02-19
RS59730B1 (sr) 2020-02-28
TW201636354A (zh) 2016-10-16
EP3250575A1 (en) 2017-12-06
HUE048029T2 (hu) 2020-05-28
AR103406A1 (es) 2017-05-10
TWI574969B (zh) 2017-03-21
ECSP17048768A (es) 2017-11-30
NZ732381A (en) 2018-05-25
AU2016211827B2 (en) 2018-04-26
US20170368071A1 (en) 2017-12-28
ZA201703937B (en) 2019-01-30
JP2019142902A (ja) 2019-08-29
UA119581C2 (uk) 2019-07-10
MA41420B1 (fr) 2020-02-28
ME03581B (me) 2020-07-20
EP3250575B1 (en) 2019-11-20
GT201700166A (es) 2018-11-23
CA2969475C (en) 2019-06-18
ES2768782T3 (es) 2020-06-23
CR20170287A (es) 2017-07-20
DK3250575T3 (da) 2020-01-20
PH12017501356A1 (en) 2017-12-11
EA201791229A1 (ru) 2017-11-30
JP2018503666A (ja) 2018-02-08
IL252754A0 (en) 2017-08-31
CL2017001899A1 (es) 2018-03-23
AU2016211827A1 (en) 2017-06-22
CN107108657A (zh) 2017-08-29
BR112017012149A2 (pt) 2018-01-02
SG11201706038PA (en) 2017-08-30
HRP20192240T1 (hr) 2020-03-06
PL3250575T3 (pl) 2020-06-01
KR20170097782A (ko) 2017-08-28
TN2017000332A1 (en) 2019-01-16
JP6723250B2 (ja) 2020-07-15
DOP2017000159A (es) 2017-07-31
CO2017007810A2 (es) 2017-10-20
PT3250575T (pt) 2020-01-16
CA2969475A1 (en) 2016-08-04
SI3250575T1 (sl) 2019-12-31
LT3250575T (lt) 2020-02-10
US10080758B2 (en) 2018-09-25
EA031330B1 (ru) 2018-12-28
WO2016122968A1 (en) 2016-08-04
CN107108657B (zh) 2021-10-08

Similar Documents

Publication Publication Date Title
ZAA201801100S (en) Jeans
IL269532A (en) Process for making analogues of an arilumin ring
PH12017501356A1 (en) Tosylate salt of n-[3-[(4ar,7as)-2-amino-6-(5-fluoropyrimidin-2-yl)-4,4a,5,7-tetrahydropyrrolo[3,4-d][1,3]thiazin-7a-yl]-4-fluoro-phenyl]-5-methoxy-pyrazine-2-carboxamide
PT3169666T (pt) Derivados sbstituidos de azaspiro(4,5)decano
CA185991S (en) One-piece garment
CO2017001927A2 (es) Formas cristalinas de n-[3-[(4ar,7as)-2-amino-6-(5- fluoropirimidin-2-il)-4,4a,5,7-tetrahidropirrolo[3,4-d][1,3]tiazin-7a-il]-4-fluoro-fenil]-5-metoxi-pirazin-2-carboxamida como inhibidores de bace
TW201612133A (en) Refractory ceramic batch as well as a refractory ceramic product
MX380240B (es) Preparación de piperidin-4-carbotioamida.
HK1241377A1 (en) Tosylate salt of n-[3-[(4ar,7as)-2-amino-6-(5-fluoropyrimidin-2-yl)-4,4a,5,7-tetrahydropyrrolo[3,4-d][1,3]thiazin-7a-yl]-4-fluoro-phenyl]-5-methoxy-pyrazine-2-carboxamide
HK40105206A (en) Process for making arylomyin ring analogs
ZAA201801528S (en) Curvify jeans
PH32018050179S1 (en) Jeans
HK40017809B (en) Process for making arylomyin ring analogs
PT3414534T (pt) Trabalho redentor de jesus cristo demonstrado em balança de pratos
IN2014CH02021A (es)
HUP1500451A2 (en) Processes for the preparation of 1,4,7-triaza-cyclononane derivatives and intermediates
AU2014901578A0 (en) The name of the invention is the attachable socks. This will help prevent babies from taking off the socks.